NFL Alumni Association partnering with healthcare companies on mobile EHR app

  • September 9, 2026
  • Esther Shein

Healthcare company DataMEDS and Tollo Health, a proprietary medical foods and nutraceutical manufacturer, have announced that they have jointly entered into a partnership with the National Football League Alumni Association, Inc. through its alumni health subsidiary (“NFLAH”).

The partnership will focus on the launch of a telehealth consumer platform, the Health Lives Here mobile application. It is designed to facilitate the consolidation of electronic health records data for patients and the integration of wearables data, while producing a streamlined health dashboard for tracking purposes and access to unique products.

The partnership, supported by DataMEDS’ pharmacy-focused subsidiary Corexa Health’s network of over 6,500 independent pharmacies, also aims to provide underserved and rural communities with:

  • increased awareness around healthy living
  • better access to discounted pharmacy services
  • improved control over patient data, and
  • access to pharmacy-based services and unique products.

“The opportunity to partner with NFL Alumni Health on the launch of the Health Lives Here Platform, which includes development of the Health Lives Here consumer app and building the Health Lives Here pharmacy network, represents a unique opportunity to drive retail customers towards their trusted pharmacist providers in a better way,’’ said Gerald E. Commissiong, founder and CEO of Tollo Health and interim co-Ceo of DataMeds, AI. “All of this is with the intention of improving patient access in order with the goal of achieving better outcomes.”

DataMEDS and Tollo introduced “Health Lives Here” to pro football alumni members, including pro football legends, during the 2026 Football Hall of Fame Game weekend in Canton, OH. The media campaign to roll out Health Lives Here to the general population is expected to begin in North Carolina this month. More details on the Health Lives Here mobile application, certified pharmacies, and staging of the campaign rollout will be detailed in a future communication in mid-September 2026, the companies said.

DataMeds AI focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units through its Health IT and physical infrastructure together with its AI platform EinsteinRx™ and smart contracts platform PharmacyChain™ with the goal of delivering a better healthcare experience for consumers. Tollo Health develops and commercializes nature-based therapeutics, in addition to its Health Lives Here telehealth platform and TolloBio biologics development programs.